Effect of Goserelin on the Protection of Ovarian Reserve During (Neo)Adjuvant Chemotherapy for Young Breast Cancer Patients: A Prospective Cohort Trial
Latest Information Update: 19 Oct 2022
At a glance
- Drugs Goserelin (Primary) ; Antineoplastics
- Indications Early breast cancer
- Focus Pharmacodynamics
- 16 Oct 2022 Planned End Date changed from 1 Dec 2021 to 31 Dec 2024.
- 16 Oct 2022 Planned primary completion date changed from 1 Dec 2020 to 31 Dec 2023.
- 16 Jun 2021 New trial record